Compare CYTK & ARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | ARW |
|---|---|---|
| Founded | 1997 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.1B |
| IPO Year | 2004 | 1994 |
| Metric | CYTK | ARW |
|---|---|---|
| Price | $61.52 | $137.09 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 18 | 3 |
| Target Price | $88.50 | ★ $124.33 |
| AVG Volume (30 Days) | ★ 1.8M | 451.6K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 49.93 |
| EPS | N/A | ★ 10.93 |
| Revenue | $13,368,000.00 | ★ $30,852,935,000.00 |
| Revenue This Year | $8.73 | $13.19 |
| Revenue Next Year | $309.93 | $4.51 |
| P/E Ratio | ★ N/A | $12.81 |
| Revenue Growth | N/A | ★ 10.49 |
| 52 Week Low | $29.31 | $86.50 |
| 52 Week High | $70.98 | $162.61 |
| Indicator | CYTK | ARW |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 38.63 |
| Support Level | $59.13 | $131.16 |
| Resistance Level | $65.72 | $161.62 |
| Average True Range (ATR) | 2.57 | 4.06 |
| MACD | 0.03 | -1.34 |
| Stochastic Oscillator | 49.44 | 29.55 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the global components business and the global enterprise computing solutions.